SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-03-09 18:37
Tx date 2026-03-08 		$ONCY
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-30,000 vol 		240,000
Filed 2026-02-13 10:34
Tx date 2026-02-12 		$ONCY
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$33,864
+40,000 vol
$0.85 each 		566,991
Filed 2026-02-13 10:32
Tx date 2026-02-11 		$ONCY
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$49,590
+60,000 vol
$0.83 each 		526,991
Filed 2026-01-20 18:16
Tx date 2026-01-16 		$ONCY
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$103,770
+100,000 vol
$1.04 each 		466,991
Filed 2025-08-22 18:24
Tx date 2025-08-18 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$162,000
+150,000 vol
$1.08 each 		270,000
Filed 2025-07-16 19:11
Tx date 2025-07-16 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+26,336 vol 		366,991
Filed 2025-07-16 19:10
Tx date 2025-07-16 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-26,336 vol 		0
Filed 2025-07-16 19:09
Tx date 2025-07-14 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+26,336 vol 		26,336
Filed 2025-06-09 18:18
Tx date 2025-06-08 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-5,263 vol 		120,000
Filed 2025-04-22 18:28
Tx date 2025-04-21 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+25,792 vol 		340,655
Filed 2025-04-22 18:27
Tx date 2025-04-21 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
57 - Exercise of rights
-25,792 vol 		0
Filed 2025-04-09 15:41
Tx date 2025-02-18 		$APS
Aptose Biosciences Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-12,888 vol 		444
Filed 2025-04-09 15:39
Tx date 2025-02-18 		$APS
Aptose Biosciences Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-16,434 vol 		566
Filed 2025-04-04 17:55
Tx date 2025-03-31 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Rights Restricted Share Units
56 - Grant of rights
+25,792 vol 		25,792
Filed 2024-12-20 16:49
Tx date 2024-12-18 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$33,900
+30,000 vol
$1.13 each 		125,263
Filed 2024-02-08 09:55
Tx date 2024-02-05 		$APS
Aptose Biosciences Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+3,333 vol 		13,332
Filed 2023-09-25 17:16
Tx date 2023-09-22 		$APS
Aptose Biosciences Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$21,895
+7,000 vol
$3.13 each 		17,000
Filed 2023-09-25 17:15
Tx date 2023-09-22 		$APS
Aptose Biosciences Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$31,400
+10,000 vol
$3.14 each 		10,000
Filed 2023-08-18 11:36
Tx date 2023-08-15 		$ONC
Oncolytics Biotech Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$82,800
+30,000 vol
$2.76 each 		95,263
Filed 2023-08-17 20:49
Tx date 2023-05-24 		$APS
Aptose Biosciences Inc. 		Seizinger, Bernd Robert
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-140,001 vol 		9,999